FDA Rules Against Approval Of New Duchenne Muscular Dystrophy Drug
After a 12-hour hearing, the FDA ruled against the approval of the newly proposed Duchenne muscular dystrophy drug tentatively branded Exondys 51.
[ Ссылка ]
Ещё видео!
FDA Rules Against Approval Of New Duchenne Muscular Dystrophy Drug
After a 12-hour hearing, the FDA ruled against the approval of the newly proposed Duchenne muscular dystrophy drug tentatively branded Exondys 51.
[ Ссылка ]